The purpose of the Chemical Dependency Training Consortium of the Northwest is to provide low-cost training for the staff, interns and volunteers of member agencies and other professional caregivers. All training provided must meet all standards of and be recognized for continuing-education credit by the National Association for Alcoholism and Drug Abuse Counselors (NAADAC), the Washington State Department of Health (DOH) and the Addiction Counselor Certification Board of Oregon (ACCBO).
SpringHill Suites by Marriott
Vancouver Columbia Tech Center
Emerging Drugs of Abuse and Utilization of Pharmacogenetics for Behavioral Health Treatment Friday, July 12th, 2019 9 a.m. to 4:30 p.m. 6 CEU Hours Sponsored By Affinity Counseling and Treatment
Water Resources Education Center 4600 SE Columbia Way, Vancouver, Washington 98661
Registration fee: $50 for Agency Members/$75 Non-member/$50 Student
Current agency members include: Affinity Counseling and Treatment, Catholic Community Services of Western Washington, Lifeline Connections, Providence Health and Services, Recovery Village at Ridgefield, and Western Psychological and Counseling Services.
Goal of Training
Emerging substances of abuse continue to be a growing and dangerous trend in the U.S. Synthetic and designer drugs can be widely available, very potent and dangerous, and difficult to identify and detect. This presentation focuses on helping clinical and medical audiences to better understand prevalence and use trends, pharmacologic actions, signs and symptoms of use, and urine drug testing (UDT) implications for emerging drugs of abuse.
Additionally, this training will introduce participants to the emerging practice of pharmacogenetic testing (PGT) and its application for improving the treatment of mental health and substance use disorders. Through use of genetic testing, providers can optimize drug therapy to ensure maximum efficacy with minimal adverse effects. Such approaches promise the advent of personalized medicine, in which drugs and drug combinations are optimized for each individual's unique genetic makeup. PGT and UDT paired with clinical expertise can provide critical information about medication and substance use and can help clinicians monitor and support decisions about medication therapy.
Behavioral Objectives Upon completion of this session participants will be able to:
Identify contemporary landscape and changing trends in drugs of misuse and abuse,
Describe consequences of drug misuse, abuse, and addiction,
Document reasons for drug testing, review of test results and use of results in the treatment plan to support medical necessity,
Discuss how genetic variations may allow clinicians to more effectively understand medication response, and
Understand how PGT may provide valuable, objective information for more personalized therapy in mental health and substance use disorder treatment.
8:30 a.m. to 9 a.m.
Registration, Meet & Greet Networking
9:00 - 9:10 a.m.
9:10 - 10:45 a.m.
Emerging Drugs of Abuse
10:45 - 11:00 a.m.
11:00 - Noon
Introduction to Fentanyl
Noon - 1:00 p.m.
1:00 - 2:15 p.m.
Opioid Use and Abuse
2:15 - 2:30 p.m.
2:30 - 4:15 p.m.
Pharmacogenics for mental health and substance use disorder treatment
4:15 - 4:30 p.m.
Trainer Kelly Olson, PhD, is the Associate Director of Clinical Affairs at Millennium Health. She is an experienced researcher in molecular neuro-pharmacology, as well as in clinical biology in the areas of mental illness, sleep, adrenal fatigue, and addictions. Dr. Olson has authored/co-authored a number of peer-reviewed articles, book chapters, and presentations, and has lectured extensively internationally, nationally, and locally. Dr. Olson has spent the majority of the past 9 years in integrative medicine, helping to improve patient clinical outcomes. She received her Masters of Science in exercise physiology from the University of North Dakota and her PhD in pharmacology and therapeutics from the University of Manitoba.
Pre-registration and payment in advance is required.
Brown Paper Tickets Ticket Widget Loading...
Click Here to visit the Brown Paper Tickets event page.
This course has been approved by CDTC as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #100385. CDTC is responsible for all aspects of their programing.
This training is approved for 6 contact hours through NAADAC.
Those participating in educational programs offered by NAADAC Approved Education Providers are assured that the continuing education (CE) credits provided for each course will be accepted toward national credentialing by the National Certification Commission for Addiction Professionals (NCC AP), as well as many of the individual state licensing/certification bodies in the addiction and other helping professionals.
The CDTC Refund/Cancellation Policy:
For full refund, cancellation of attendance must be received by the CDTC at least 3 days prior to the event.
Cancellations made in less than 3 days of the event are subject to a $15 handling charge. Occasionally, changes are made due to speaker availability or unforeseen circumstances. The CDTC will send out an email announcement to the registration contact and provide an update on our website.
If we are aware of bad weather in the area, the CDTC will extend the full refund deadline to include the morning of the training. The CDTC still must receive notice of cancellation of attendance prior to 10 a.m.
Lunch is included with this training.
Friday, July 12th, 2019 9 a.m. to 4:30 p.m.
Water Resource Center
4600 SE Columbia Way,
Vancouver, WA 98661
To keep interruptions at a minimum, it is requested that all cell phones and pagers
be turned off during the training. Due to state-manadated temperatures, the thermostats
in our classrooms are set and cannot be changed.